Original Research

Published on 03 Mar 2022

Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients

in Inflammation Pharmacology

M. Vomero
M. Caliste
C. Barbati
M. Speziali
A. I. Celia
F. Ucci
C. Ciancarella
E. Putro
T. Colasanti
G. Buoncuore

Frontiers in Pharmacology

doi 10.3389/fphar.2022.852802

3,413 views
13 citations

Review

Published on 03 Mar 2022

Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies

in Inflammation Pharmacology

Patrizia Ballerini
Annalisa Contursi
Annalisa Bruno
Matteo Mucci
Stefania Tacconelli
Paola Patrignani

Frontiers in Pharmacology

doi 10.3389/fphar.2022.838079

9,583 views
36 citations

Review

Published on 02 Mar 2022

The Research Progress of Exosomes in Osteoarthritis, With Particular Emphasis on the Therapeutic Effect

in Inflammation Pharmacology

Shang Xian Bo
Wang Chen
Liu Chang
Yu Hao Ran
Guo Hui Hui
Zhu Ya Kun
Xie Wu Kun
Fan Hai Tao
Cheng Wen Dan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.731756

4,940 views
6 citations

Review

Published on 02 Mar 2022

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?

in Inflammation Pharmacology

Nils Helge Schebb
Hartmut Kühn
Astrid S. Kahnt
Katharina M. Rund
Valerie B. O’Donnell
Nicolas Flamand
Marc Peters-Golden
Per-Johan Jakobsson
Karsten H. Weylandt
Nadine Rohwer

Frontiers in Pharmacology

doi 10.3389/fphar.2022.838782

22,130 views
105 citations

Original Research

Published on 01 Mar 2022

Sulforaphane Modulates the Inflammation and Delays Neurodegeneration on a Retinitis Pigmentosa Mice Model

in Inflammation Pharmacology

Antolín Canto
Javier Martínez-González
María Miranda
Teresa Olivar
Inma Almansa
Vicente Hernández-Rabaza

Frontiers in Pharmacology

doi 10.3389/fphar.2022.811257

4,498 views
12 citations

Case Report

Published on 28 Feb 2022

Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19

in Inflammation Pharmacology

Valentina Fanny Leone
Amantia Imeraj
Sara Gastoldi
Caterina Mele
Lucia Liguori
Carmelita Condemi
Piero Ruggenenti
Giuseppe Remuzzi
Camillo Carrara

Frontiers in Pharmacology

doi 10.3389/fphar.2022.842473

2,042 views
6 citations

Original Research

Published on 28 Feb 2022

Direct Thrombin Inhibitor Dabigatran Compromises Pulmonary Endothelial Integrity in a Murine Model of Breast Cancer Metastasis to the Lungs; the Role of Platelets and Inflammation-Associated Haemostasis

in Inflammation Pharmacology

Marta Smeda
Marta Stojak
Kamil Przyborowski
Magdalena Sternak
Joanna Suraj-Prazmowska
Kamil Kus
Katarzyna Derszniak
Agnieszka Jasztal
Agnieszka Kij
Anna Kurpinska

Frontiers in Pharmacology

doi 10.3389/fphar.2022.834472

3,232 views
7 citations

Review

Published on 25 Feb 2022

New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases

in Inflammation Pharmacology

Wenxiang Hong
Bo Yang
Qiaojun He
Jiajia Wang
Qinjie Weng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.841687

12,938 views
39 citations

Original Research

Published on 24 Feb 2022

Notoginsenoside R1 (NG-R1) Promoted Lymphatic Drainage Function to Ameliorating Rheumatoid Arthritis in TNF-Tg Mice by Suppressing NF-κB Signaling Pathway

in Inflammation Pharmacology

Danli Jiao
Yang Liu
Tong Hou
Hao Xu
Xiaoyun Wang
Qi Shi
Yongjun Wang
Qiujuan Xing
Qianqian Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.730579

3,167 views
14 citations

Original Research

Published on 23 Feb 2022

Pentamidine Alleviates Inflammation and Lipopolysaccharide-Induced Sepsis by Inhibiting TLR4 Activation via Targeting MD2

in Inflammation Pharmacology

Siru Wu
Cong Lin
Tianshu Zhang
Bo Zhang
Yushan Jin
Hongshuang Wang
Hongyuan Li
Yibo Wang
Xiaohui Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.835081

4,620 views
9 citations

Original Research

Published on 22 Feb 2022

Steroid Treatment in Macular Edema: A Bibliometric Study and Visualization Analysis

in Inflammation Pharmacology

Yu Lin
Xiang Ren
Danian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.824790

7,894 views
14 citations

Review

Published on 22 Feb 2022

Autophagy-Inflammation Interplay During Infection: Balancing Pathogen Clearance and Host Inflammation

in Inflammation Pharmacology

Yuqian Pang
Lanxi Wu
Cheng Tang
Hongna Wang
Yongjie Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2022.832750

7,001 views
33 citations

Original Research

Published on 21 Feb 2022

Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR−/− Mice

in Inflammation Pharmacology

Yifan Zhang
Min Du
Jiarou Wang
Ping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.828161

3,802 views
23 citations

Review

Published on 18 Feb 2022

Platelets in Non-alcoholic Fatty Liver Disease

in Inflammation Pharmacology

Andrea Dalbeni
Marco Castelli
Mirko Zoncapè
Pietro Minuz
David Sacerdoti

Frontiers in Pharmacology

doi 10.3389/fphar.2022.842636

13,784 views
10 citations

Review

Published on 18 Feb 2022

Autophagy and Skin Diseases

in Inflammation Pharmacology

Kim Klapan
Dagmar Simon
Alexander Karaulov
Marina Gomzikova
Albert Rizvanov
Shida Yousefi
Hans-Uwe Simon

Frontiers in Pharmacology

doi 10.3389/fphar.2022.844756

10,893 views
27 citations

Original Research

Published on 17 Feb 2022

An RRx-001 Analogue With Potent Anti-NLRP3 Inflammasome Activity but Without High-Energy Nitro Functional Groups

in Inflammation Pharmacology

Hualong Lin
Mingyang Yang
Cong Li
Bolong Lin
Xianming Deng
Hongbin He
Rongbin Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.822833

4,314 views
8 citations

Navigation group

Articles

Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients

Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies

The Research Progress of Exosomes in Osteoarthritis, With Particular Emphasis on the Therapeutic Effect

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?

Sulforaphane Modulates the Inflammation and Delays Neurodegeneration on a Retinitis Pigmentosa Mice Model

Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19

Direct Thrombin Inhibitor Dabigatran Compromises Pulmonary Endothelial Integrity in a Murine Model of Breast Cancer Metastasis to the Lungs; the Role of Platelets and Inflammation-Associated Haemostasis

New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases

Notoginsenoside R1 (NG-R1) Promoted Lymphatic Drainage Function to Ameliorating Rheumatoid Arthritis in TNF-Tg Mice by Suppressing NF-κB Signaling Pathway

Pentamidine Alleviates Inflammation and Lipopolysaccharide-Induced Sepsis by Inhibiting TLR4 Activation via Targeting MD2

Steroid Treatment in Macular Edema: A Bibliometric Study and Visualization Analysis

Autophagy-Inflammation Interplay During Infection: Balancing Pathogen Clearance and Host Inflammation

Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR−/− Mice

Platelets in Non-alcoholic Fatty Liver Disease

Autophagy and Skin Diseases

An RRx-001 Analogue With Potent Anti-NLRP3 Inflammasome Activity but Without High-Energy Nitro Functional Groups